Form 4 for GTBP GT Biopharma, Inc.
Accepted 2023-08-15 00:00:00 ET · period of report 2023-08-11 · accession 0001493152-23-029061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-15 | 2023-08-11 | GTBP | Breen Michael Martin | Executive COB, Interim CEO, Dir | A - Grant | $0.29 | +200.0K | 856.2K | +30% | +$58.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-11 | A | A | 200,000 | $0.29 | 856,218 | D | — | — |